Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)

SHA:603229 Revenue

Zhejiang Ausun Pharmaceutical had revenue of 164.09M CNY in the quarter ending September 30, 2025, a decrease of -17.01%. This brings the company's revenue in the last twelve months to 751.12M, down -10.07% year-over-year. In the year 2024, Zhejiang Ausun Pharmaceutical had annual revenue of 795.29M, down -2.63%.

• Revenue (ttm): 751.12M
• Revenue Growth: -10.07%
• P/S Ratio: 10.88
• Revenue / Employee: 616.18K
• Employees: 1,219
• Market Cap: 8.18B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	795.29M	-21.48M	-2.63%
Dec 31, 2023	816.77M	52.22M	6.83%
Dec 31, 2022	764.55M	194.85M	34.20%
Dec 31, 2021	569.70M	160.45M	39.21%
Dec 31, 2020	409.25M	101.33M	32.91%